Skip to main content
Fig. 6 | BMC Cardiovascular Disorders

Fig. 6

From: Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)

Fig. 6

Difficult-to-treat patients at baseline categorised by dose groups. *A patient is considered as a high risk patient if he/she has at least one of the following: prior stroke, prior major bleeding, prior ICH or (calculated) CHA2DS2-VASc ≥4. There was no specific definition for frailty; it was left to the discretion of the physician to categorise a patient as frail

Back to article page